熱門資訊> 正文
Sanuwave Health在与专利销售相关的500万美元付款后上涨
2025-08-23 03:11
- Sanuwave (NASDAQ:SNWV) shares rose after it announced that it has received a $5M cash payment from its third-party licensee in connection with the exercise of a previously granted acquisition option.
- The payment stems from an exclusive license and option agreement originally executed on March 6, 2024, between Sanuwave and a third-party licensee.
- Under that agreement, Sanuwave granted the licensee exclusive rights to utilize a portfolio of patents focused on intravascular shockwave applications.
- In exchange for those rights and the option to acquire the patents outright, the licensee paid Sanuwave a one-time licensing fee of $2.5M.
- The stock is up 8% today.
More on SANUWAVE Health
- SANUWAVE Health, Inc. 2025 Q2 - Results - Earnings Call Presentation
- SANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call Transcript
- Sanuwave: High Growth Wound Care Tech Primed For A Breakout
- SANUWAVE outlines Q3 revenue target of $12M–$12.7M as new applicator production nears launch
- Seeking Alpha’s Quant Rating on SANUWAVE Health
推薦文章
9月30日外盤頭條：特朗普會見國會兩院領導人 勞工統計局稱政府關門時將暫停運作 瑞士擬投資美國黃金精煉業
美股機會日報 | 警報拉響！「巴菲特指標」暗示美股已高估？現貨黃金突破3800美元大關
中國資產「強勢崛起」！華爾街齊呼：全球投資者正不斷增持中國股票
黃金又雙叒叕破紀錄！政府停擺與美聯儲迷霧成最佳推手
華盛早報 | 七年來首次政府關門真要來了？特朗普放狠話要關就關；中國央行：要落實落細適度寬松的貨幣政策
一周財經日曆 | 美國9月大小非農數據重磅來襲！紫金黃金國際、西普尼等3只新股下周上市
港股周報丨阿里加碼AI投入引爆股價！小米發佈會后急跌8%，大摩稱仍看好公司長期價值
對俄施壓升級，油價有望實現強勁周漲幅
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
